Awards

2026 Early Career Investigator Abstract Awards

The Crohn’s & Colitis Congress has awarded five Early Career Investigators Abstract Awards to selected investigators who will be presenting their work at the 2026 meeting. Recipients are early-career researchers, either currently in training or within five year of completing their training, and are presenting authors of abstracts selected for poster presentation.

Bianca Islam, MD, PhD
Case Western Reserve University

REPOSITIONING DUAL GLP-1/GIP RECEPTOR AGONISTS FOR THE TREATMENT OF COLITIS AND COLITIS-ASSOCIATED TUMORIGENESIS

Ji Yeon Kim, PhD
University of Colorado Anschutz Medical Campus

INDOLE ACETIC ACID AS AN INHIBITOR OF MYELOPEROXIDASE-MEDIATED BYSTANDER TISSUE DAMAGE IN INFLAMMATORY BOWEL DISEASE

Erifili Lianopoulou, MSc
Alexander Fleming Biomedical Sciences Research Center

CD8+ T-CELLS DEFINE SEX-SPECIFIC RESPONSES TO IL-23 TREATMENT IN CD

Marina Macchi, MD
Children’s Hospital of Philadelphia

QUANTITATIVE SMALL BOWEL MOTILITY ASSESSMENT ON MAGNETIC RESONANCE ENTEROGRAPHY IN PEDIATRIC CROHN DISEASE: ASSOCIATIONS WITH CLINICAL PHENOTYPE AND SURGICAL OUTCOME

Alfredo Ornelas, Ph.D.
University of Colorado Anschutz Medical Campus

METABOLITE MIMICRY REVEALS BUTYRATE ANALOG WITH SELECTIVE PROTECTIVE FUNCTIONS IN THE INTESTINAL MUCOSA

The Crohn’s & Colitis Congress will provide Early Career Investigators Abstract Awards to up to ten abstract presenters for the 2026 meeting. Award recipients will receive complimentary registration for the 2026 Congress.

The award application site is now closed.

Applicants for the award must:

  • Be listed as the presenting author of an abstract accepted for presentation at the 2026 Crohn’s & Colitis Congress.
  • Be an early-career researcher (i.e., currently in training or within 5 years of completing their training).
  • Applied by 9 p.m. EDT on Wednesday, Sept. 24, 2025.

Applications must have been submitted online. No mailed, emailed, or faxed applications will be accepted.

Previous recipients of the award are not eligible to apply.

Award notifications will be emailed on Tuesday, Nov. 18, 2025.

Contact info@crohnscolitiscongress.org with any questions.

Submit an Application

2025 Award Recipients

Bianca Islam, MD, PhD Case Western Reserve University REPOSITIONING DUAL GLP-1/GIP RECEPTOR AGONISTS FOR THE TREATMENT OF COLITIS AND COLITIS-ASSOCIATED TUMORIGENESIS Ji Yeon Kim, PhD University of Colorado Anschutz Medical Campus INDOLE ACETIC ACID AS AN INHIBITOR OF MYELOPEROXIDASE-MEDIATED BYSTANDER TISSUE DAMAGE IN INFLAMMATORY BOWEL DISEASE Erifili Lianopoulou, MSc Alexander Fleming Biomedical Sciences Research Center CD8+ T-CELLS DEFINE SEX-SPECIFIC RESPONSES TO IL-23 TREATMENT IN CD Marina Macchi, MD Children’s Hospital of Philadelphia QUANTITATIVE SMALL BOWEL MOTILITY ASSESSMENT ON MAGNETIC RESONANCE ENTEROGRAPHY IN PEDIATRIC CROHN DISEASE: ASSOCIATIONS WITH CLINICAL PHENOTYPE AND SURGICAL OUTCOME Alfredo Ornelas, Ph.D. University of Colorado Anschutz Medical Campus METABOLITE MIMICRY REVEALS BUTYRATE ANALOG WITH SELECTIVE PROTECTIVE FUNCTIONS IN THE INTESTINAL MUCOSA

Hailey DiCindio, Tufts University School of Medicine

RACIAL DISPARITIES ON ACCEPTANCE OF BIOLOGIC AND SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SURVEY STUDY

Jacques Gonzales, Michigan State University

NEURONAL PANNEXIN-1 SHAPES IMMUNE PROFILE AND INTESTINAL FUNCTIONS

William Massey, Cleveland Clinic Lerner Research Institute

MICROBIAL TRIMETHYLAMINE HOST TRACE AMINE ASSOCIATED RECEPTOR 5 (TAAR5) SIGNALING EXERTS PRO-FIBROTIC PROPERTIES IN IBD

Sidra Naz, MD Anderson Cancer Center

REGIONAL AND RACIAL DISPARITIES IN ULCERATIVE COLITIS AND CHOLANGIOCARCINOMA RELATED MORTALITY IN THE UNITED STATES AND TEXAS: A 21 YEAR OBSERVATIONAL STUDY

Ronaldo Paolo Panganiban, Penn State College of Medicine

TARGETING MYD88-JAK2 SIGNALING IN ABERRANTLY DIFFERENTIATED MESENCHYMAL PROGENITORS IN ULCERATIVE COLITIS

Application Information

The Crohn’s & Colitis Congress will award complementary registration to the 2022 meeting to up to ten young investigators and five nurses and advanced practice providers. Applications will be accepted from 9 a.m. EDT on Wednesday, Sept. 8 through 9 p.m. EDT on Wednesday, Oct. 20, 2022. 

Applicants are:

  • Early career investigators currently in training or within five years of completing their training.
  • Listed as the presenting author of an abstract accepted for oral or poster presentation at the 2021 Crohn’s & Colitis Congress..

Recipients will receive complementary registration to the 2021 meeting.

The deadline for young investigators and nurses to submit an application for complementary registration to the 2022 meeting has passed. 

Notifications will be sent to all applicants in early December. 

Young Investigators Abstract Awards

  • Congress administration will award up to ten young investigators complementary registration for the 2024 Congress.
  • Applicants for the award must be an early career investigator currently in training or within five years of completing their training; additionally, applicants must be listed as the presenting author of an abstract accepted for presentation at the 2024 Crohn’s & Colitis Congress.
  • To apply, complete and submit all three award questions as part of an abstract submission by 9 p.m. EDT on Wednesday, Oct. 18, 2023.
  • Applicants will be asked to briefly describe their career stage and how Congress attendance will benefit their career in 4000 or fewer characters.
  • Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.
  • Prior award recipients are not eligible to receive a 2024 award.
  • Award notifications will be emailed to applicants in December 2023.

Applicants for the Young Investigators Abstract Award must be:

  • Early career investigators currently in training or within five years of completing their training.
  • Listed as the presenting author of an abstract accepted for oral or poster presentation at the 2022 Crohn’s & Colitis Congress.

Applications may be submitted at the abstract submission site. To apply for the award, complete the “Awards” fields when submitting an abstract. Applicants are asked to verify their eligibility and also provide a brief (4000 characters maximum) personal statement.

Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.

Applications are due at the abstract submission site by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.

Contact Congress administration with any questions about applying.

Nurses/Advanced Practice Providers Award

  • The Crohn’s & Colitis Congress will award up to five nurses or advanced practice providers complimentary registration to the 2023 Crohn’s & Colitis Congress.
  • Applicants for the Nurses/Advanced Practice Providers Award must be a registered nurse, clinical nurse specialist, nurse practitioner, or physician assistant in any practice setting currently involved in IBD patient management. Graduate students in any of the listed fields with an identified interest in the IBD patient population will also be considered.
  • Applications for the Nurses/Advanced Practice Providers Award will be accepted online through 12 p.m. (noon) EDT on Friday, Oct. 21, 2022.
  • To apply for the award, applicants must submit the following materials:
    • Current curriculum vitae.
    • Estimate of the average number of IBD patients seen weekly in your practice setting.
    • A brief (500 words or fewer) statement as to why attending the Crohn’s & Colitis Congress is important to you and the patients you manage. Please state the significance your participation in this conference will have on your practice, patient care or knowledge of IBD. Include how you will share your experience with others (if applicable), list any questions you hope this conference will help answer, or share any ideas or projects that you hope to develop further as a result of attending this conference.
  • Previous recipients of the award are not eligible to receive a 2023 award.
  • Award notifications will be sent by email in December 2022.

Nurses and advanced practice providers may apply for complementary registration to the 2022 Crohn’s & Colitis Congress.

As part of the application, applicants are asked to submit their CV and a brief (500 words or less) personal statement.

Applications must be submitted by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.

Contact Congress administration with any questions about applying.

This website uses cookies to provide you with the best experience on our website. If you wish to disable cookies, please do so in your browser settings. Your continued use of our site without disabling your cookies is subject to the cookie policy. Learn More

I agree